Zhi-Xian Wu (Zhixian Wu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Radical Prostatectomy

Patient Reported Outcomes

Peritoneal Dialysis

Top Venues

Journal of clinical and translational hepatology

Disease markers

British journal of cancer

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Linbin Lu, Peichan Zheng, Yan Pan, Shanshan Huang, Erqian Shao, Yan Huang, Xuewen Wang, Yaying Chen, Gongbao Cuo, Hongyi Yang, Wangting Guo, Yanhong Shi, Zhi-Xian Wu, Xiong Chen
Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving atezolizumab plus bevacizumab: a secondary analysis of IMbrave150 study. British journal of cancer (2023)
Jing Lin, Miao-Fang Su, Jiao-Long Zheng, Lei Gu, Hai-Cong Wu, Xia Wu, Hai-Yan Lin, Zhi-Xian Wu, Dong-Liang Li
Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis. Journal of clinical and translational hepatology 11 (3) (2022)
Jing Lin, Miao-Fang Su, Jiao-Long Zheng, Lei Gu, Hai-Cong Wu, Xia Wu, Hai-Yan Lin, Zhi-Xian Wu, Dong-Liang Li
Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis. Journal of clinical and translational hepatology 11 (3) (2022)
Shasha Li, Qian Huang, Dongliang Li, Lizhi Lv, Yi Li, Zhi-Xian Wu
The significance of Stanniocalcin 2 in malignancies and mechanisms. Bioengineered 12 (1) (2022)
Zhongyuan Cui, Lijia Xiao, Fengsui Chen, Jielong Wang, Haiyan Lin, Dong-Liang Li, Zhi-Xian Wu
High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients. Disease markers 2021 (2021)
Chen Lin, Lina Sun, Shenglei Huang, Xiangqun Weng, Zhi-Xian Wu
STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition. BioMed research international 2019 (2019)